Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 16:2022:9617319.
doi: 10.1155/2022/9617319. eCollection 2022.

Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East

Affiliations

Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East

Reema A Karasneh et al. Int J Clin Pract. .

Abstract

This study aimed to assess the risk factors for COVID-19 mortality among hospitalized patients in Jordan. All COVID-19 patients admitted to a tertiary hospital in Jordan from September 20, 2020, to August 8, 2021, were included in this study. Demographics, clinical characteristics, comorbidities, and laboratory results were extracted from the patients' electronic records. Multivariable logistic and machine learning (ML) methods were used to study variable importance. Out of 1,613 COVID-19 patients, 1,004 (62.2%) were discharged from the hospital (survived), while 609 (37.8%) died. Patients who were of elderly age (>65 years) (OR, 2.01; 95% CI, 1.28-3.16), current smokers (OR, 1.61; 95%CI, 1.17-2.23), and had severe or critical illness at admission ((OR, 1.56; 95%CI, 1.05-2.32) (OR, 2.94; 95%CI, 2.02-4.27); respectively), were at higher risk of mortality. Comorbidities including chronic kidney disease (OR, 2.90; 95% CI, 1.90-4.43), deep venous thrombosis (OR, 2.62; 95% CI, 1.08-6.35), malignancy (OR, 2.22; 95% CI, 1.46-3.38), diabetes (OR, 1.31; 95% CI, 1.04-1.65), and heart failure (OR, 1.51; 95% CI, 1.02-2.23) were significantly associated with increased risk of mortality. Laboratory abnormalities associated with mortality included hypernatremia (OR, 11.37; 95% CI, 4.33-29.81), elevated aspartate aminotransferase (OR, 1.81; 95% CI, 1.42-2.31), hypoalbuminemia (OR, 1.75; 95% CI, 1.37-2.25), and low platelets level (OR, 1.43; 95% CI, 1.05-1.95). Several demographic, clinical, and laboratory risk factors for COVID-19 mortality were identified. This study is the first to examine the risk factors associated with mortality using ML methods in the Middle East. This will contribute to a better understanding of the impact of the disease and improve the outcome of the pandemic worldwide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
Variable reduction based on the consensus variable importance extracted from multiple ML methods. Variables highlighted in black color represent variables selected for the final multiple logistic regression model.
Figure 2
Figure 2
Sunburst chart with nested rings illustrating the hierarchical breakdown of identified risk factors segmented by patients' outcome, that is, death versus discharge.
Figure 3
Figure 3
Receiver Operator Characteristic (ROC) charts for the Multiple Logistic Regression model compared to the multiple ML methods used for variable reduction.

Similar articles

Cited by

References

    1. Gorbalenya A. E., Baker S. C., Baric R. S., et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology . 2020;5 doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. Gebru A. A., Birhanu T., Wendimu E., et al. Global burden of COVID-19: situational analyis and review. Human Antibodies . 2021;29(2):139–148. doi: 10.3233/hab-200420. - DOI - PubMed
    1. World health organization WHO coronavirus (COVID-19) dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data . Geneva, Switzerland: WHO; 2021. pp. 1–5.
    1. Islam N., Shkolnikov V. M., Acosta R. J., et al. Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ . 2021;373 doi: 10.1136/bmj.n1137.n1137 - DOI - PMC - PubMed
    1. Chan E. Y. S., Cheng D., Martin J. Impact of COVID-19 on excess mortality, life expectancy, and years of life lost in the United States. PLoS One . 2021;16(9) doi: 10.1371/journal.pone.0256835.e0256835 - DOI - PMC - PubMed